Heart Failure

Safety and Feasibility Assessment of the Doraya, a Renal Venous Afterload Modulator, for the Treatment of Volume Overload in Acute Heart Failure Patients with Insufficient Response to Diuretics

10 min.

Structural Remodeling of the Failing LV: Concepts and Devices

15 min.

Interatrial Shunts: Devices, Clinical Results, and Future Prospects

14 min.

Transcatheter Pulmonary Artery Banding In Chronic Heart Failure [HFrEF]: Results From the First-in-Human Study

8 min.

Pre-Clinical Results With A Chronically-Adjustable And Pressure Sensing Interatrial Shunt (Adona Medical)

11 min.

MIRTH Ventriculoplasty (Myocardial Intramural Remodeling by Endovenous TeTHer)

12 min.

Ventricular Unloading and Reverse Remodeling in Heart Failure

26 min.

Long-term Outcomes of Endovascular Baroreflex Amplification in Symptomatic Patients With HFrEF

11 min.

Transcatheter Pulmonary Artery Banding in Chronic Heart Failure: Results From an Early Feasibility Study

11 min.

The PRELIEVE Trial: Responder Analysis in the HFpEF Subgroup Regarding Baseline PVR, Pacemaker and Pressure Gradients

11 min.

Physiological Modeling at Rest and Exercise of a Novel Right-to-Right Cardiac Shunt

15 min.

Novel Imaging Methods and Interventions of the Lymphatic System

13 min.

The Lymphatic System and The Role in Heart Failure

13 min.

Harnessing the Lymphatic System the Treat Heart Failure

23 min.

No-Implant Interatrial Shunt for Heart Failure With Preserved and Mildly Reduced Ejection Fraction: Six-Month Outcomes From Multi-Center Pilot Feasibility Studies

12 min.

Clinical Feasibility of a Novel Right-to-Right Cardiac Shunt in Pulmonary Hypertension using Off-the-Shelf Devices

12 min.

Shunt Devices in Pulmonary Hypertension Management

10 min.

Splanchnic Nerve Denervation for HFrEF and HFpEF

8 min.

Cardiac Contractility Modulation for HFrEF and HFpEF: Impulse Dynamics

9 min.

Mechanical Stimulation of the Carotid Sinus: MobiusHD

5 min.

Aortic Arch Simulation (Enopace)

8 min.

Vagal Nerve Stimulation (ANTHEM)

8 min.

Baroreflex Activation Therapy (BAT) in Patients With Heart Failure and a Reduced Ejection Fraction (BeAT-HF): Long-Term Outcomes

9 min.

Obesity in Heart Failure with Preserved Ejection Fraction: Insights from the REDUCE LAP-HF II Trial

10 min.

Impact of the V-Wave® Ventura® Interatrial Shunt Device on Right and Left Ventricular Structure and Function: Complete 12-Month Results of the RELIEVE-HF Roll-in Cohort

10 min.

Vsling, A Left Ventricular Transcatheter Repair Device for HFrEF Patients

14 min.

IFPx - A Minimally-Invasive Multiparameter Remote Heart Failure Sensor With Integrated Interstitial Pressure Measurement

13 min.

Syntach Cardiac Support System - Minimally Invasive Fully Implantable Cardiac Support Technology To Restore Cardiac Function In Heart Failure Patients

14 min.

Acorai Save Sensor - A Novel Non-Invasive Multi-Sensor Medical Device For Measurement And Estimation Of Absolute Intracardiac Pressure, Enabling Early Detection And Ongoing Management Of Heart Failure Patients And Pulmonary Hypertension

11 min.

Corstasis - Intranasal Diuretic for the Treatment of CHF Refractory to Oral Diuretics.

15 min.

THT Shark Tank Winner Announcement

3 min.

Device-Based LV Remodeling as a Therapy for HFrEF: MIRTH - Myocardial Intramural Remodeling by Transvenous Tether

6 min.

Device-Based LV Remodeling as a Therapy for HFrEF: CardiacSuccess / V-Sling

5 min.

Device-Based LV Remodeling as a Therapy for HFrEF: CardiacDimensions

7 min.

Device-Based LV Remodeling as a Therapy for HFrEF: Bioventrix

7 min.

Device-Based LV Remodeling as a Therapy for HFrEF: Ancora

7 min.

Biological vs Physical Reverse Remodeling in Heart Failure: Implications for Device-Based Therapies for HFrEF

10 min.

Strengths and Limitations of a Two-Phase (6-Month Intermediate Endpoints & 12-18 Month Mortality and Heart Failure Hospitalization) Design for Trials on Chronic Heart Failure Devices

10 min.

Regulatory Aspects for Chronic Heart Failure Devices - FDA Perspective

10 min.

Pros and Cons of the Win Ratio as the Primary Endpoint for Pivotal Heart Failure Trial

10 min.

Interatrial Shunts for the Treatment of Heart Failure: InterShunt - Cut, Capture and Leave Nothing Behind

8 min.

Interatrial Shunts for the Treatment of Heart Failure: The Occlutech AFR - Matching Shunt Length and Diameter to the Patient

7 min.

Interatrial Shunts for the Treatment of Heart Failure: V-Wave - Different Shape, Different Effect?

6 min.

Interatrial Shunts for the Treatment of Heart Failure: LA to Coronary Sinus - The Edwards APTURE Shunt

4 min.

Interatrial Shunts for the Treatment of Heart Failure: Implications of Left Atrial Hypertension at Rest and Exercise

8 min.

Interventional Therapies for HFpEF

9 min.

Does this patient have HFpEF and if so how to treat? - Mystery Case 1

14 min.

Does this patient have HFpEF and if so how to treat? - Mystery Case 2

9 min.

Interatrial Shunts for the Treatment of Heart Failure: What We Know and What We Don't Know

11 min.

Interatrial Shunts for the Treatment of Heart Failure: Alleviant - Leave Nothing Behind

6 min.

Assessing the Residual Risk: What Gaps Should New Technologies Fill?

8 min.

Position 2: Hey… What About Creating an Atrial Shunt for Heart Failure

12 min.

The Current Status of Interatrial Shunts for HFrEF and HFpEF (Importance of Hemodynamic Exercise Testing)

11 min.

A Left Ventricular Transcatheter Repair Device for HFrEF (Cardiac Success Vsling)

7 min.

Myocardial Intramural Remodeling by Endovenous TeTHer (MIRTH)

7 min.

Reshaping the Failing Heart From the Coronary Sinus: The Carillon Device and Pivotal Study

9 min.

Excluding the Infarcted LV Apical Segment of the Heart: The Bioventrix Device and Pivotal Study

12 min.

Reshaping the Failing Heart From Inside the LV Chamber: The Accucinch Device and Pivotal Study

9 min.

Reshaping the Failing Heart by Tethering the Bases of the Papillary Muscles

7 min.

Overview of Device-Based Therapies for Heart Failure

8 min.

Pulmonary to Venous Shunt for Group 2 PH-HFpEF (NXT™ Rivet)

8 min.